Brave Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,686
| Closed | -$36K | – | 157 |
|
|
2017
Q2 | $36K | Hold |
3,686
| – | – | 0.02% | 141 |
|
|
2017
Q1 | $89K | Buy |
3,686
+1,907
| +107% | +$46K | 0.05% | 142 |
|
|
2016
Q4 | $57K | Sell |
1,779
-128
| -7% | -$4.1K | 0.04% | 145 |
|
|
2016
Q3 | $95K | Buy |
1,907
+636
| +50% | +$31.7K | 0.06% | 180 |
|
|
2016
Q2 | $54K | Hold |
1,271
| – | – | 0.04% | 216 |
|
|
2016
Q1 | $84K | Hold |
1,271
| – | – | 0.06% | 184 |
|
|
2015
Q4 | $79K | Buy |
1,271
+254
| +25% | +$15.8K | 0.05% | 189 |
|
|
2015
Q3 | $68K | Hold |
1,017
| – | – | 0.05% | 191 |
|
|
2015
Q2 | $99K | Sell |
1,017
-127
| -11% | -$12.4K | 0.07% | 171 |
|
|
2015
Q1 | $107K | Sell |
1,144
-127
| -10% | -$11.9K | 0.08% | 163 |
|
|
2014
Q4 | $113K | Sell |
1,271
-508
| -29% | -$45.2K | 0.08% | 159 |
|
|
2014
Q3 | $123K | Buy |
1,779
+635
| +56% | +$43.9K | 0.09% | 154 |
|
|
2014
Q2 | $66K | Buy |
+1,144
| New | +$66K | 0.05% | 202 |
|